HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Income from Continuing Operations
HLS Therapeutics Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Income from Continuing Operations
-$27.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Income from Continuing Operations
-CA$4.8m
|
CAGR 3-Years
-97%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-31%
|
See Also
What is HLS Therapeutics Inc's Income from Continuing Operations?
Income from Continuing Operations
-27.5m
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Income from Continuing Operations amounts to -27.5m USD.
What is HLS Therapeutics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-2%
Over the last year, the Income from Continuing Operations growth was -17%. The average annual Income from Continuing Operations growth rates for HLS Therapeutics Inc have been -22% over the past three years , -2% over the past five years .